Shopping Cart
- Remove All
- Your shopping cart is currently empty
Tauro-obeticholic acid, a farnesoid X receptor (FXR) agonist and semisynthetic derivative of chenodeoxycholic acid, is an active metabolite of obeticholic acid. This compound undergoes taurine conjugation in the liver to form from obeticholic acid and can be reconverted to its original form by intestinal microflora.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $397 | 35 days | |
5 mg | $1,620 | 35 days |
Description | Tauro-obeticholic acid, a farnesoid X receptor (FXR) agonist and semisynthetic derivative of chenodeoxycholic acid, is an active metabolite of obeticholic acid. This compound undergoes taurine conjugation in the liver to form from obeticholic acid and can be reconverted to its original form by intestinal microflora. |
Alias | T-ECDCA, Tauro-OCA, Tauro-6-Ethylchenodeoxycholic Acid, Tauro-6-Ethyl-CDCA, Obeticholic Acid Taurine Conjugate |
Molecular Weight | 549.74 |
Formula | C28H48NO6S.Na |
Cas No. | 2278141-79-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | Ethanol: 20 mg/ml PBS pH 7.2: 2 mg/ml DMSO: 20 mg/ml DMF: 20 mg/ml |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.